Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 26Brain Neoplasms 23Lung Neoplasms 17Neoplasm Metastasis 15Breast Neoplasms 12Melanoma 9Carcinoma, Renal Cell 8Pancreatic Neoplasms 6Colorectal Neoplasms 6Carcinoma, Hepatocellular 4Urinary Bladder Neoplasms 3Neoplasms 3NSCLC 3Meningioma 3Gastrointestinal Neoplasms 3Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Sarcoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Epidural Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

Specimen Handling 6Human Papillomavirus DNA Tests 4Colposcopy 4Papillomavirus Vaccines 2Human Papillomavirus Recombinant Vaccine nonavalent 2Cisplatin 2Carboplatin 2toripalimab 1epigallocatechin gallate 1Transurethral Resection of Prostate 1Standing Orders 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Platinum 1Methods 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Educational Status 1Early Intervention, Educational 1Drug Therapy 1Docetaxel 1Clinical Protocols 1Chemoradiotherapy 1Bevacizumab 1Benzethonium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × Radiosurgery × 90 days × Clear all
NCT07578467 2026-05-11

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

University of Pennsylvania

Phase 1/2 Not yet recruiting
35 enrolled

Carcinoma, Squamous Cell, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡